VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 47 filers reported holding VENTYX BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $916,872 | +5.9% | 26,400 | 0.0% | 0.78% | +20.2% |
| Q2 2023 | $865,920 | +97854.8% | 26,400 | 0.0% | 0.65% | -6.2% |
| Q1 2023 | $884 | +22.6% | 26,400 | +20.0% | 0.69% | +36.0% |
| Q4 2022 | $721 | -100.0% | 22,000 | -51.1% | 0.51% | -54.0% |
| Q3 2022 | $1,571,000 | +288.9% | 45,000 | +36.4% | 1.11% | +276.2% |
| Q2 2022 | $404,000 | +19.2% | 33,000 | +32.0% | 0.29% | +20.5% |
| Q1 2022 | $339,000 | -31.8% | 25,000 | 0.0% | 0.24% | -23.8% |
| Q4 2021 | $497,000 | – | 25,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 3,461,536 | $113,503,765 | 35.19% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $24,473,472 | 32.37% |
| Vivo Capital, LLC | 1,303,294 | $42,735 | 4.92% |
| ACUTA CAPITAL PARTNERS, LLC | 290,500 | $7,558,095 | 4.65% |
| TCG Crossover Management, LLC | 787,231 | $25,813,304 | 4.56% |
| Affinity Asset Advisors, LLC | 240,623 | $7,890,028 | 3.09% |
| GREAT POINT PARTNERS LLC | 400,695 | $13,138,789 | 2.58% |
| Logos Global Management LP | 657,016 | $21,543,555 | 2.52% |
| Cormorant Asset Management, LP | 1,080,643 | $35,434 | 2.37% |
| Boxer Capital, LLC | 850,000 | $27,871,500 | 1.47% |